Works matching DE "TYPE 2 diabetes

Results: 5000
    1
    2
    3
    4
    5
    6
    7

    Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi Consensus.

    Published in:
    Diabetes Therapy, 2025, v. 16, n. 8, p. 1707, doi. 10.1007/s13300-025-01762-3
    By:
    • Bruglia, Matteo;
    • Cardini, Francesca;
    • Di Luzio, Raffaella;
    • Fiorini, Stefania;
    • Guberti, Antonella;
    • Haddoub, Silvia;
    • Preiato, Valentina Lo;
    • Luberto, Alessandra;
    • Lugli, Francesca;
    • Maiello, Massimiliano;
    • Manicardi, Elisa;
    • Marcellini, Marco Marcello;
    • Monesi, Marcello;
    • Pellicano, Francesca;
    • Piani, Daniela;
    • Trianni, Rosa Maria;
    • Vacirca, Anna;
    • Nicolucci, Antonio;
    • Di Bartolo, Paolo
    Publication type:
    Article
    8
    9

    Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.

    Published in:
    Diabetes Therapy, 2025, v. 16, n. 8, p. 1597, doi. 10.1007/s13300-025-01750-7
    By:
    • Layton, J. Bradley;
    • Ziemiecki, Ryan;
    • Johannes, Catherine B.;
    • Pladevall-Vila, Manel;
    • Khan, Anam M.;
    • Ebert, Natalie;
    • Kovesdy, Csaba P.;
    • Christiansen, Christian Fynbo;
    • García-Sempere, Aníbal;
    • Kanegae, Hiroshi;
    • Coleman, Craig I.;
    • Walsh, Michael;
    • Andersen, Ina Trolle;
    • Rodríguez-Bernal, Clara;
    • Cabaniñas, Celia Robles;
    • Thomsen, Reimar W.;
    • Farjat, Alfredo E.;
    • Gay, Alain;
    • Gee, Patrick;
    • Hurtado, Isabel
    Publication type:
    Article
    10
    11
    12
    13

    Targeting the molecular crosstalk between diabetes and lung cancer for therapeutic intervention.

    Published in:
    Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03264-x
    By:
    • Azani, Alireza;
    • Avval, Nahal Aghajamal;
    • Meigoli, Mohammad Saeed Soleimani;
    • Imankhan, Mahshid;
    • Asgari, Pouya;
    • Ebrahimisaraj, Gholamreza;
    • Morovatshoar, Reza;
    • Hosseini, Ahmad Mir;
    • Mirzohreh, Seyedeh Tarlan;
    • Nouri, Masoumeh;
    • Bostanabad, Hossein Azari;
    • Behfar, Qumars;
    • Bayrami, Fahimeh;
    • Sharafi, Malihe
    Publication type:
    Article
    14
    15

    Differential effects of GLP-1 receptor agonists on diabetic osteopathy in type 2 diabetes: a patient-stratified network meta-analysis.

    Published in:
    BMC Musculoskeletal Disorders, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12891-025-09022-y
    By:
    • Alalwani, Yazan Jumah;
    • Alshahrani, Ali Saad;
    • Alsudays, Aseel Ibrahem;
    • Almutairi, Reema Nasser Awad;
    • Arab, Rana Ali Hassan;
    • Alqahtani, Reema Safar Ali;
    • Alrefaei, Omar Saad;
    • Alqahtani, Rana;
    • Ofaysan, Meshal Salman Bin;
    • Azzam, Ahmed Y.;
    • Alomran, Ammar K.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    The retina as a window into detecting subclinical cardiovascular disease in type 2 diabetes.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-13468-4
    By:
    • Alatrany, Abbas S.;
    • Lakhani, Kishan;
    • Cowley, Alice C.;
    • Yeo, Jian L.;
    • Dattani, Abhishek;
    • Ayton, Sarah L.;
    • Deshpande, Aparna;
    • Graham-Brown, Matthew P.M.;
    • Davies, Melanie J.;
    • Khunti, Kamlesh;
    • Yates, Thomas;
    • Sellers, Stephanie L.;
    • Zhou, Huiyu;
    • Brady, Emer M.;
    • Arnold, Jayanth R.;
    • Deane, James;
    • McLean, Rebecca J.;
    • Proudlock, Frank A.;
    • McCann, Gerry P.;
    • Gulsin, Gaurav S.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02875-6
    By:
    • Abdel Jawad, Mohammad;
    • Furtado, Remo H. M.;
    • Esterline, Russell;
    • Oscarsson, Jan;
    • Gasparyan, Samvel B.;
    • Koch, Gary G.;
    • Martinez, Felipe;
    • Mukhtar, Omar;
    • Verma, Subodh;
    • Langkilde, Anna Maria;
    • Ambery, Philip;
    • Patel, Shachi;
    • Gosch, Kensey;
    • Windsor, Sheryl L.;
    • Soares, Ronaldo V. P.;
    • Moia, Diogo D. F.;
    • Aboudara, Matthew;
    • Javaheri, Ali;
    • Saraiva, J. F. Kerr;
    • Maia, Lilia Nigro
    Publication type:
    Article
    42

    Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02850-1
    By:
    • Weerts, Jerremy;
    • Schroen, Blanche L. M.;
    • Barandiarán Aizpurua, Arantxa;
    • Berendschot, Tos T. J. M.;
    • Brandts, Lloyd;
    • Webers, Carroll A. B.;
    • Simons, Sami O.;
    • Meex, Steven J. R.;
    • Henry, Ronald;
    • van der Kallen, Carla J. H.;
    • Brunner-La Rocca, Hans-Peter;
    • Knackstedt, Christian;
    • Heymans, Stephane R. B.;
    • de Boer, Rudolf A.;
    • van Empel, Vanessa P. M.;
    • Houben, Alfons J. H. M.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50